Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

Taking a low dose of daily aspirin is known to have some health benefits. For example, it can help reduce the risk of heart ...

Aspirin reduced colorectal cancer recurrence risk by 50% in patients with PIK3CA mutations over three years. Mutations in the PI3K pathway predict aspirin response, broadening its use to more patients ...

One study found daily aspirin reduced the risk of colon or rectal cancer recurrence, but another saw no significant survival ...

A large international clinical trial led by the National Cancer Center Singapore has found that taking aspirin for three years after standard therapy for high-risk colorectal cancer does not ...

Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the risk of cancer ...

Please provide your email address to receive an email when new articles are posted on . Low-dose aspirin significantly reduced risk for colorectal cancer recurrence among patients with mutations ...

A new study has found that taking a small daily dose of aspirin could help stop colon cancer from returning in some patients. The research shows that a 160-milligram aspirin pill each day can cut ...

29, 2025 (HealthDay News) -- Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of aspirin a day cuts the ...

A randomized study has produced some hopeful news for colorectal cancer survivors with an unlikely suspect: the commonly used over-the-counter aspirin. “Patients with treated, PI3K-mutated early ...

WEDNESDAY, Jan. 29, 2025 (HealthDay News) -- Daily low-dose aspirin can help prevent cancers from returning in about a third of colon cancer patients, a new study says. Taking 160 milligrams of ...